Conferences are back—the good, the bad, and the ugly. Each attendee experiences their own personal journey of unanticipated surprises, small misfortunes, physical and mental challenges, beneath the general background chaos. A constellation of unknown glittering prizes draws us back each year. In some ways, it feels like being part of an instinctual migratory movement. We are swept up in the excitement of the new, whilst transformed through reunification with the old.
It was my personal pleasure to be part of the 30-year celebration award dinner for the International Pharmaceutical Excipients Council (IPEC). Over friendly and informed conversation (I sat beside Stephen Hoag from the university of Maryland), we enjoyed a fabulous meal while hearing from five new scientists the salient points of their award-winning research. One of these, Rishi Thakar from the University of Texas at Austin, employed one of my favorite technologies—selective laser sintering—to improve formulation porosity when dealing with poorly soluble APIs. I had not previously appreciated in any real sense the potential benefits of 3D printed drugs.
At the AAPS, PharmSci 360 event in Philadelphia and INTERPHEX in New York City, we assembled in large numbers huddled around gleaming machines in capacious exhibit halls. We met at intimate restaurants with new sales prospects, or past colleagues. We sat in classroom-like auditoriums to hear scientific presentations redolent of our university youth. And we arranged site visits to local suppliers or customers.
A high point for me came when my normal office self, and my conference embodiment, both meet the author of an article that had earlier grabbed my attention while editing it. Nitin Swarnakar from BASF wrote an absorbing piece on Self Emulsifying Drug Delivery Systems. Within the article was a small section that had eluded my full comprehension, and I had made a physical note to return to the literature at some future point to clarify. Especially to better understand how this small aspect connected to the wider world of biology. Nitin was delighted to share what he knew at our booth, while to rest of the conference world swirled ceaselessly in the background. This happenstance genuinely made my day. Conferences are like that, they frustrate, and they exhaust, but serendipity and comradery draw us back. Year after year.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.